Neurology News

A health innovations company has acquired a portfolio of electroencephalograph-related brain monitoring technologies and devices from an applied science firm to bolster its pipeline of products geared toward telehealth in neurology.

Poor sleep quality and low energy on the previous day were associated with incident morning headache, while higher than average energy levels and stress were linked to later-day headache onset, researchers reported in Neurology.

The popular trend of Dry January is coming to a close for the year, but it helped spark interest in the benefits of abstaining from alcohol, even for just a month.

The FDA has approved a rechargeable deep brain stimulation device with remote programming for individuals living with movement disorders, according to the manufacturer.

The European Commission has approved Hyqvia as maintenance therapy for individuals of all ages with chronic inflammatory demyelinating polyneuropathy.

Mild traumatic brain injuries may raise the risk for affective and behavioral disorders in children, according to research published in Pediatrics.

The FDA has approved Gammagard Liquid as an IV immunoglobulin therapy to improve neuromuscular disability and impairment in adults with chronic inflammatory demyelinating polyneuropathy.

Isaac Health has raised $5.7 million to help identify and care for individuals with different cognitive and brain health conditions in the United States.

Approximately one-third of clinicians working in academic settings expressed intentions to leave their current institution within the next 2 years, survey results revealed.

The FDA has granted orphan drug designation to an investigational therapeutic to treat myotonic dystrophy type 1, the most common form of muscular dystrophy in adults, according to its manufacturer.